Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001723128-19-000129

Options or other derivatives

  • SVP, Chief Scientific Officer acquired 153,846 shares (grant or award)
  • SVP, Chief Scientific Officer returned 153,846 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Bhadauria Pradeep SVP, Chief Scientific Officer 2019-11-13 Returned to the company · Stock Option −153,846 0 D
Bhadauria Pradeep SVP, Chief Scientific Officer 2019-11-13 Grant or award · Stock Option +153,846 153,846 D
Loading xslF345X03/wf-form4_157377039293557.xml…